Cardiac involvement in pediatric patients with inherited metabolic disease
Pediatrics International · 2026
DOI: 10.1111/ped.70344 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, 2026. Verfasst von Gamzegül Gözen Bayramoğlu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye. Hauptthemen laut MEDLINE: Metabolism, Inborn Errors, Cardiomyopathies, Metabolic Diseases, Heart Diseases. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Inherited metabolic diseases (IMDs) are genetic disorders characterized by metabolic defects leading to toxic accumulation or deficiencies in essential molecules. Cardiovascular complications, including cardiomyopathy (CM), valve dysfunction (VD), and arrhythmias, significantly contribute to morbidity and mortality in IMD patients, necessitating comprehensive cardiac evaluation. This study investigates the relationship between IMDs and cardiovascular involvement in pediatric patients to inform clinical management.
Methods
A retrospective analysis was conducted on 1215 pediatric IMD patients (2012–2021). Cardiovascular involvement was assessed through clinical records, echocardiography, and laboratory findings. Patients with congenital heart defects were excluded.
Results
Among 85 IMD patients with cardiovascular involvement, the median age was 85 months, with a 20‐month follow‐up. CM was present in 57.6%, most commonly hypertrophic CM. VD was identified in 40%, and vasculopathy in 4.7%. Rhythm abnormalities occurred in 8.2%, with two cases of clinically significant arrhythmias. Energy metabolism disorders were most associated with CM (71.8%), while VD was predominant in lipoprotein metabolism disorders (66.7%). Cardiac involvement was most frequently detected in infancy (45.9%). Disease progression occurred in 60% of intoxication‐type and 41% of energy metabolism disorders. The mortality rate was 21.2%, higher in CM patients (22.4%) than in those with VD (17.6%).
Conclusion
Cardiovascular complications impose a substantial burden on pediatric IMD patients. Early detection and a multidisciplinary approach are crucial for improving outcomes. Comprehensive cardiac assessment and tailored interventions can mitigate risks, highlighting the need for further multicenter studies to refine management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye.
- Division of Pediatric Metabolism, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye.
- Rare Diseases Research and Application Center, Ankara University, Ankara, Türkiye.
- Division of Pediatric Cardiology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Türkiye.
ORCID-Profile: Gamzegül Gözen Bayramoğlu, Engin Köse, Ümmühan Öncül, Begüm Murt, Mehmet Gökhan Ramoğlu, Tayfun Uçar, Fatma Tuba Eminoğlu
Zitieren
APA
Gözen Bayramoğlu, G., Köse, E., Öncül, Ü., Murt, B., Ramoğlu, M. G., Uçar, T., & Eminoğlu, F. T. (2026). Cardiac involvement in pediatric patients with inherited metabolic disease. Pediatrics International. https://doi.org/10.1111/ped.70344
Vancouver
Gözen Bayramoğlu G, Köse E, Öncül Ü, Murt B, Ramoğlu MG, Uçar T, et al. Cardiac involvement in pediatric patients with inherited metabolic disease. Pediatrics International. 2026. doi:10.1111/ped.70344
BibTeX
@article{GzenBayramolu2026,
author = {Gözen Bayramoğlu, Gamzegül and Köse, Engin and Öncül, Ümmühan and Murt, Begüm and Ramoğlu, Mehmet Gökhan and Uçar, Tayfun and Eminoğlu, Fatma Tuba},
title = {Cardiac involvement in pediatric patients with inherited metabolic disease},
journal = {Pediatrics International},
year = {2026},
doi = {10.1111/ped.70344}
}
EUVIMED